NCT03164785View on ClinicalTrials.gov

Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

September 26, 2020

Study Completion Date

December 8, 2022

Conditions
Type 2 Diabetes MellitusDiabetic Kidney Disease
Interventions
DRUG

Jinshuibao Capsule

1.98g t.i.d. p.o. for 6 months

Trial Locations (1)

410011

The Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Second Xiangya Hospital of Central South University

OTHER

NCT03164785 - Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease | Biotech Hunter | Biotech Hunter